Actinium Pharmaceuticals
ATNM
#9930
Rank
โ‚ฌ31.69 M
Marketcap
1,02ย โ‚ฌ
Share price
-1.64%
Change (1 day)
-11.77%
Change (1 year)

Market capitalization of Actinium Pharmaceuticals (ATNM)

Market cap: โ‚ฌ31.69 Million

As of February 2026 Actinium Pharmaceuticals has a market cap of โ‚ฌ31.69 Million. This makes Actinium Pharmaceuticals the world's 9930th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Actinium Pharmaceuticals from 2011 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ31.69 M-21.48%
2025โ‚ฌ40.36 M12.21%
2024โ‚ฌ35.97 M-71.44%
2023โ‚ฌ0.12 B-50.21%
2022โ‚ฌ0.25 B115.3%
2021โ‚ฌ0.11 B5.69%
2020โ‚ฌ0.11 B247.38%
2019โ‚ฌ32 M-18.23%
2018โ‚ฌ39.14 M-11.56%
2017โ‚ฌ44.25 M-4.56%
2016โ‚ฌ46.37 M-64.38%
2015โ‚ฌ0.13 B-10.32%
2014โ‚ฌ0.14 B38.54%
2013โ‚ฌ0.10 B331.91%
2012โ‚ฌ24.25 M2467.34%
2011โ‚ฌ0.94 M

End of Day market cap according to different sources

On Feb 2nd, 2026 the market cap of Actinium Pharmaceuticals was reported to be:

โ‚ฌ32.08 Million
by Nasdaq info icon info icon
โ‚ฌ32.22 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Genocea Biosciences
GNCA
โ‚ฌ0 M-99.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚ฌ3.79 B 11,866.57%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ9.36 B 29,465.08%๐Ÿ‡บ๐Ÿ‡ธ USA